Duality Advisers’s Dentsply Sirona XRAY Stock Holding History

Duality Advisers’s Portfolio XRAY Stock Details XRAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-35,141	Closed	-$1.17M	–	547
2024 Q1	$1.17M	Buy	+35,141	New	+$1.2M	0.12%	290
2023 Q4	–	Sell	-68,560	Closed	-$2.34M	–	769
2023 Q3	$2.34M	Buy	68,560 +57,680	+530%	+$2.19M	0.28%	123
2023 Q2	$435K	Buy	+10,880	New	+$433K	0.05%	408
2022 Q3	–	Sell	-55,267	Closed	-$1.98M	–	772
2022 Q2	$1.98M	Sell	55,267 -40,447	-42%	-$1.64M	0.19%	196
2022 Q1	$4.71M	Buy	+95,714	New	+$5.06M	0.51%	27
2021 Q4	–	Sell	-89,328	Closed	-$5.18M	–	711
2021 Q3	$5.18M	Sell	89,328 -1,643	-2%	-$101K	0.4%	70
2021 Q2	$5.75M	Buy	+90,971	New	+$5.99M	0.51%	40
2019 Q4	–	Sell	-61,560	Closed	-$3.28M	–	450
2019 Q3	$3.28M	Buy	+61,560	New	+$3.31M	0.18%	168
2019 Q1	–	Sell	-302,920	Closed	-$11.3M	–	286
2018 Q4	$11.3M	Buy	+302,920	New	+$11M	0.66%	33

Other funds holding XRAY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Nuance Investments Kansas City, Missouri $717M AUM 3.8% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Duality Advisers's XRAY Position: Q2 2024 in Review

Duality Advisers sold out of Dentsply Sirona (XRAY) in Q2 2024, closing a stake of 35,141 shares — an estimated $1.17M sold.

Duality Advisers first reported a position in XRAY in Q4 2018 and held it in 9 quarters. The position peaked at $11.3M in Q4 2018. 381 funds tracked by Wall St. Rank hold XRAY as of Q2 2024.

Duality Advisers reported no remaining Dentsply Sirona position as of Q2 2024 after selling out during the quarter.
Duality Advisers sold 35,141 Dentsply Sirona shares in Q2 2024, an estimated $1.17M.
Duality Advisers first reported a position in Dentsply Sirona in Q4 2018 and held it in 9 quarters.
Duality Advisers's Dentsply Sirona position peaked at $11.3M in Q4 2018.
381 funds tracked by Wall St. Rank held Dentsply Sirona as of Q2 2024.

Based on Duality Advisers's 13F filing for Q2 2024.